Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain). 1979

J Peetermans, and R M du Pan, and C Huygelen

In 1967-1968 a trial of "Cendehill strain" rubella vaccine was initiated in a group of 3 to 22 year-old prescreened seronegative girls, most being between 8 and 16 years of age. Sera from the vaccinees were taken at regular intervals during a period of 8 to 10 years. The evolution of the antibodies was followed over this period. No antibody titer change was observed in 75 to 78% of the sera. A four fold increase was shown in 6 to 10% and a four fold decrease in 15% of the vaccinees. All sera still showed a positive titer at the end of the period. The importance of these results for the final objective of rubella vaccination will be discussed.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012409 Rubella An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM. Measles, German,Three Day Measles,German Measles,Measle, Three Day,Measles, Three Day,Rubellas,Three Day Measle
D012411 Rubella Vaccine A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed) Vaccine, Rubella

Related Publications

J Peetermans, and R M du Pan, and C Huygelen
January 1969, Antimicrobial agents and chemotherapy,
J Peetermans, and R M du Pan, and C Huygelen
July 1971, The Practitioner,
J Peetermans, and R M du Pan, and C Huygelen
September 1970, The Journal of hygiene,
J Peetermans, and R M du Pan, and C Huygelen
April 1970, Minerva medica,
J Peetermans, and R M du Pan, and C Huygelen
April 1970, Southern medical journal,
J Peetermans, and R M du Pan, and C Huygelen
September 1969, The Journal of pediatrics,
J Peetermans, and R M du Pan, and C Huygelen
May 1972, Canadian Medical Association journal,
J Peetermans, and R M du Pan, and C Huygelen
June 1980, British medical journal,
J Peetermans, and R M du Pan, and C Huygelen
July 1969, The Journal of pediatrics,
J Peetermans, and R M du Pan, and C Huygelen
August 1969, American journal of diseases of children (1960),
Copied contents to your clipboard!